HEALTHIER FOOD RETAIL
Professor Anna Peeters AM, PhD
Chief Executive Officer, VicHealth, Victoria, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | July 2026
Professor Anna Peeters AM is a globally recognised public health leader whose career has spanned academia, policy and health system reform, with a strong focus on prevention and health equity. She is the CEO of VicHealth, bringing decades of experience in epidemiology, population health and evidence-based health promotion.
Prior to her appointment as CEO, Professor Peeters was Director of the Institute for Health Transformation at Deakin University and a Professor of Epidemiology and Equity in Public Health. In this role, she led multidisciplinary research addressing major health challenges including obesity, chronic disease, health system sustainability and health outcome inequities. She has also held leadership roles at the Baker Heart and Diabetes Institute and the Australia and New Zealand Obesity Society and has contributed to national and international advisory bodies.
Professor Peeters is widely recognised for her research into obesity prevention, food systems and the social determinants of health. She established the world-first RE-FRESH Centre of Research Excellence in healthier food retail environments, advancing practical solutions to improve population diets and reduce health inequities. Her work has consistently focused on translating evidence into policy and real-world impact at scale.
A Fellow of the Australian Academy of Health and Medical Sciences and a Member of the Order of Australia, Professor Peeters continues to shape prevention systems through a strong emphasis on equity and collaboration.
Source: Supplied
-
Pancreatic and lung cancers driven by mutations in the cancer gene KRAS
Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors). -
Cellular interactions responsible for development, maintenance, and strength of the skeleton
Professor Sims directs the Bone Cell Biology and Disease Unit at St. Vincent’s Institute of Medical Research and is a Professorial Fellow at The University of Melbourne and Australian Catholic University.
She leads a team who studies the cellular interactions responsible for development, maintenance, and strength of the skeleton. She completed her PhD at the University of Adelaide, followed by postdoctoral work at the Garvan Institute in Sydney then at Yale School of Medicine, in New Haven, Connecticut, where she studied the role of the estrogen receptor in regulating bone structure.
-
Food and fasting periods as medicine to prevent disease
Professor Leonie Heilbronn is based at the South Australian Health and Medical Research Institute (SAHMRI), where she leads the Obesity and Metabolism laboratory. Her research is at the interface between basic and clinical science. She is internationally recognised for her work in nutritional modulation in humans and has made major contributions to our current understanding of mechanisms underlying conditions such as insulin resistance, particularly inflammation and lipid metabolism. She has also contributed significantly to current concepts of caloric restriction (CR), intermittent fasting (IF) and time restricted eating (TRE) in humans. She has published more than 110 peer reviewed papers in scientific journals and is an Associate Editor of Obesity, and Obesity Research and Clinical Practice.
